1081 related articles for article (PubMed ID: 29981289)
21. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.
Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J
Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095
[TBL] [Abstract][Full Text] [Related]
22. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of HOXA-AS2 suppresses proliferation and induces apoptosis in colorectal cancer.
Tong G; Wu X; Cheng B; Li L; Li X; Li Z; Nong Q; Chen X; Liu Y; Wang S
Am J Transl Res; 2017; 9(10):4545-4552. PubMed ID: 29118916
[TBL] [Abstract][Full Text] [Related]
24. The integrated comprehension of lncRNA HOXA-AS3 implication on human diseases.
Yao Q; Wang C; Wang Y; Zhang X; Jiang H; Chen D
Clin Transl Oncol; 2022 Dec; 24(12):2342-2350. PubMed ID: 35986859
[TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori infection induces gastric cancer cell malignancy by targeting HOXA-AS2/miR-509-3p/MMD2 axis.
Cheng S; Jia Y; Wu J; Li J; Cao Y
Genes Genomics; 2024 Jun; 46(6):647-657. PubMed ID: 38573409
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of lncRNA HOXA-AS2 Inhibits Viability, Migration and Invasion of Osteosarcoma Cells by miR-124-3p/E2F3.
Wang L; Wang L; Zhang X
Onco Targets Ther; 2019; 12():10851-10861. PubMed ID: 31853184
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of HOXA-AS2 LncRNA in Patients with Gastric Cancer and Its Association with Helicobacter pylori Infection.
Rajabi A; Riahi A; Shirabadi-Arani H; Moaddab Y; Haghi M; Safaralizadeh R
J Gastrointest Cancer; 2022 Mar; 53(1):72-77. PubMed ID: 33174119
[TBL] [Abstract][Full Text] [Related]
28. HOXA-AS2 contributes to regulatory T cell proliferation and immune tolerance in glioma through the miR-302a/KDM2A/JAG1 axis.
Zhong C; Tao B; Li X; Xiang W; Peng L; Peng T; Chen L; Xia X; You J; Yang X
Cell Death Dis; 2022 Feb; 13(2):160. PubMed ID: 35181676
[TBL] [Abstract][Full Text] [Related]
29. LncRNA HOXA-AS2 Activates the Notch Pathway to Promote Cervical Cancer Cell Proliferation and Migration.
Wu Q; Lu S; Zhang L; Zhao L
Reprod Sci; 2021 Oct; 28(10):3000-3009. PubMed ID: 34076871
[TBL] [Abstract][Full Text] [Related]
30. Integrated RNA Sequencing and Single-Cell Mass Cytometry Reveal a Novel Role of LncRNA HOXA-AS2 in Tumorigenesis and Stemness of Hepatocellular Carcinoma.
Lu Q; Gao J; Tang S; Li Z; Wang X; Deng C; Hu J; Tao Y; Wang Q
Onco Targets Ther; 2020; 13():10901-10916. PubMed ID: 33149607
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA HOXA-AS2 acts as an oncogene by targeting miR-145-3p in human non-small cell lung cancer.
Shi YB; Liu SL; Mou XR; Liao J; Che JP; Fei XQ; Wang AR
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1243-1249. PubMed ID: 32096154
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer.
Ding J; Xie M; Lian Y; Zhu Y; Peng P; Wang J; Wang L; Wang K
Oncogenesis; 2017 Jan; 6(1):e288. PubMed ID: 28112720
[TBL] [Abstract][Full Text] [Related]
33. LncRNA HOXA-AS2 accelerates the proliferation and migration and inhibits the apoptosis of vascular smooth muscle cells by absorbing miRNA-877-3p.
Fan TT; Liu YX; Wang XC; Xu BL; Chen ZC; Lu HA; Zhang M
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):362-368. PubMed ID: 31957850
[TBL] [Abstract][Full Text] [Related]
34. LncRNA HOXA-AS2 Promotes Tumor Progression by Suppressing miR-567 Expression in Oral Squamous Cell Carcinoma.
Chen R; Wang X; Zhou S; Zeng Z
Cancer Manag Res; 2021; 13():5443-5455. PubMed ID: 34267554
[TBL] [Abstract][Full Text] [Related]
35. Microarray Analysis of Long Non-Coding RNAs in Lung Tissues of Patients with COPD and HOXA-AS2 Promotes HPMECs Proliferation via Notch1.
Zhou AY; Zhao YY; Zhou ZJ; Duan JX; Zhu YZ; Cai S; Chen P
Int J Chron Obstruct Pulmon Dis; 2020; 15():2449-2460. PubMed ID: 33116460
[TBL] [Abstract][Full Text] [Related]
36. Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis.
Chen WM; Huang MD; Kong R; Xu TP; Zhang EB; Xia R; Sun M; De W; Shu YQ
Dig Dis Sci; 2015 Jun; 60(6):1655-62. PubMed ID: 25686741
[TBL] [Abstract][Full Text] [Related]
37. LncRNA HOXA-AS2 represses endothelium inflammation by regulating the activity of NF-κB signaling.
Zhu X; Liu Y; Yu J; Du J; Guo R; Feng Y; Zhong G; Jiang Y; Lin J
Atherosclerosis; 2019 Feb; 281():38-46. PubMed ID: 30658190
[TBL] [Abstract][Full Text] [Related]
38. Long Non-Coding RNA HOXA-AS2 Enhances The Malignant Biological Behaviors In Glioma By Epigenetically Regulating RND3 Expression.
Wu L; Zhu X; Song Z; Chen D; Guo M; Liang J; Ding D; Wang W; Yan D
Onco Targets Ther; 2019; 12():9407-9419. PubMed ID: 31819475
[TBL] [Abstract][Full Text] [Related]
39. The dual functions of the long noncoding RNA CASC15 in malignancy.
Gu X; Chu Q; Zheng Q; Wang J; Zhu H
Biomed Pharmacother; 2021 Mar; 135():111212. PubMed ID: 33433353
[TBL] [Abstract][Full Text] [Related]
40. A novel long non-coding RNA FGF14-AS2 is correlated with progression and prognosis in breast cancer.
Yang F; Liu YH; Dong SY; Ma RM; Bhandari A; Zhang XH; Wang OC
Biochem Biophys Res Commun; 2016 Feb; 470(3):479-483. PubMed ID: 26820525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
